Flu cases may be ‘starting to settle’ in some areas, NHS chief says Sir Jim Mackey gave evidence to the Health and Social Care Committee. Evening Standard · Dec 17, 2025
Dismay as UK government halts cash for world-renowned Covid programme Despite its trials saving thousands during the pandemic, funding is being stopped for the groundbreaking UK Recovery programme The Guardian - UK · Mar 3, 2024
Trial to focus on finding treatments for ‘annual scourge’ of influenza Flu can kill between 290,000 and 650,000 people globally each year, according to the World Health Organisation. The Independent UK · Oct 30, 2023
Top scientists warn Brits ‘the next pandemic is coming and we’re not ready’ Experts say Britain is no more prepared for another pandemic as it was three years ago when Covid struck due to defunding of research and dismantling of key services Daily Mirror · Apr 17, 2023
'Flu is back' after Covid pandemic as cases start to rise People are urged to get their jab Wales Online · Nov 2, 2022
‘Flu is back’ – scientists warn of risk to NHS as data shows early rise in cases Generally, flu cases go up in December and January but experts have already seen a rise in cases. The Independent UK · Nov 2, 2022
Monkeypox: New treatment trial launched by Covid researchers ‘It’s crucial that we invest in developing, refining and evaluating treatments for this disease’, says chief trial scientist The Independent UK · Aug 23, 2022
Brit scientists launch world first clinical trial to assess monkeypox treatment The Platinum trial will be the first randomised controlled trial of a treatment for monkeypox in humans in the world Evening Standard · Aug 23, 2022
The inside story of the ground-breaking Covid-19 Recovery trial When the effectiveness of dexamethasone was first announced, it changed the treatment of the disease overnight, Guilherme Pessoa-Amorim, Leon Peto and Mark Campbell explain how they did it The Independent UK · Jul 9, 2022
Director of new pandemic institute urges government to prepare UK for next outbreak Professor Sir Peter Horby tells global leaders ‘to put your money where your mouth is’ and invest in pandemic preparedness The Independent UK · Jul 5, 2022
The inside story of Recovery: how the world’s largest COVID-19 trial transformed treatment – and what it could do for other diseases Guilherme – June 16, 2020. Evening TV news shows across the world were suddenly opening with the result of our research, and rightly so. Dexamethasone was the first drug to be shown to save the lives of people infected with COVID-19. To a young researcher like me, that day felt… The Conversation · Jun 15, 2022
Monkeypox: UK ‘detecting more cases on a daily basis’, says doctor Monkeypox, which is related to the now eradicated smallpox virus, is endemic in parts of west and central Africa Evening Standard · May 22, 2022
Monkeypox could have 'massive impact' on sexual health services, doctor warns Workers at sexual health clinics could be stretched thin by monkeypox cases. Daily Record · May 21, 2022
Monkeypox could have 'massive impact' on sexual health A top doctor said services dealing with sexual health could be heavily affected due to isolation Wales Online · May 21, 2022
The Independent UK · May 21, 2022 Monkeypox could have ‘massive impact’ on sexual health services, doctor warns The disease, first found in monkeys, can be transmitted from person to person through close physical contact – including sexual intercourse .
The Guardian - UK · Apr 27, 2022 China detects first human case of H3N8 bird flu strain Experts say widespread transmission of flu in birds is increasing scope for avian viruses to mix and mutate
Benzinga · Mar 3, 2022 Eli Lilly's JAK Inhibitor Baricitinib Cuts Death Risk By 13% In COVID-19 Patients According to a British study, Eli Lilly And Co (NYSE:LLY) and Incyte Corporation's (NASDAQ:INCY) Olumiant (baricitinib) reduced the risk of death in hospitalized COVID-19 patients by 13%. According to a Reuters report, more than 8,000 patients were administered baricitinib in addition to standard of care in the RECOVERY Trial. Results showed that 546 patients…